临床外科杂志 ›› 2025, Vol. 33 ›› Issue (7): 762-.doi: 10.3969/j.issn.1005-6483.20240797

• 论著 • 上一篇    下一篇

复制激活因子C2对肾细胞癌细胞增殖和迁移的影响及机制研究

昌莉 詹凡 田良   

  1. 430015 武汉,武汉市红十字会医院泌尿外科
  • 收稿日期:2024-05-25 出版日期:2025-07-20 发布日期:2025-07-20
  • 通讯作者: 田良,Email:332748296@qq.com

The effect and mechanism of replication activating factor C2 on proliferation and migration of renal cell carcinoma cells

CHANG Li,ZHAN Fan,TIAN Liang   

  1. Department of Urology,Wuhan Red Cross Hospital,Wuhan 430015,China
  • Received:2024-05-25 Online:2025-07-20 Published:2025-07-20

摘要: 目的 研究复制激活因子C2(RFC2)对肾细胞癌(RCC)细胞增殖和迁移的影响及机制。 方法 采用蛋白印迹测定人正常肾小管上皮细胞系HK-2及RCC细胞系ACHN、786-O、Caki-1、KETR3、OS-RC2中RFC2蛋白表达。对KETR-3细胞系采用转染试剂Lipofectamine 3000分别转染RFC2小干扰RNA(siRNA)及对照抑制序列scramble,并分成RFC2沉默表达组(si-RFC2)及抑制对照组(si-NC)。转染RFC2过表达质粒(RFC2-plasmid)及空白对照质粒,并分成RFC2过表达组(OE-RFC2)及过表达对照组(Vector)。细胞增殖能力检测采用噻唑兰(MTT)细胞增殖检测试剂盒,细胞迁移能力检测采用细胞划痕实验测定,蛋白印迹测定RFC2 、p-PI3K、PI3K、p-Akt及Akt蛋白表达水平。结果 与人正常肾小管上皮细胞系HK-2比较,RCC细胞系ACHN、786-O、Caki-1、KETR3及OS-RC2中RFC2蛋白呈高表达(均P<0.05)。MTT实验显示,si-RFC2组在0、24、48、72小时时A490nm值均低于si-NC组(P<0.05),OE-RFC2组在0、24、48、72小时时A490nm值均高于Vector组(P<0.05)。OE-RFC2组细胞划痕愈合率高于Vector组[(89.4±9.4)% 和(15.8±6.3)%,P<0.05]。si-RFC2组细胞划痕愈合率低于si-NC组[(5.2±1.9)% 和(16.5±5.5)%,P<0.05]。在KETR-3细胞中上调RFC2表达后,OE-RFC2组RFC2蛋白相对表达量高于Vector组(1.04±0.19 和 0.25±0.03,P<0.05),OE-RFC2组p-PI3K/PI3K比值高于Vector组(1.15±0.23 和 0.34±0.024,P<0.05),OE-RFC2组p-Akt/Akt比值高于Vector组(1.26±0.25 和 0.38±0.022,P<0.05)。沉默RFC2表达后,si-RFC2组RFC2蛋白相对表达量低于si-NC组(0.16±0.02 和 1.08±0.06,P<0.05),si-RFC2组p-PI3K/PI3K比值低于si-NC组(0.18±0.04 和 0.86±0.14,P<0.05),si-RFC2组p-Akt/Akt比值低于si-NC组(0.10±0.01 和 0.58±0.13,P<0.05)。结论 RFC2促进RCC细胞增殖和迁移,机制可能与激活PI3K/Akt信号通路有关。

关键词: 复制激活因子C2, 肾细胞癌, 细胞增殖, 细胞迁移, 机制

Abstract: Objective To investigate the effects and mechanisms of replication activating factor C2(RFC2) on the proliferation and migration of renal cell carcinoma(RCC) cells.Methods Western blotting was used to determine and compare the expression levels of RFC2 protein in human normal renal tubular epithelial cell lines HK-2 and RCC cell lines ACHN,786-O,Caki-1,KETR3,and OS-RC2.The KETR-3 cell line was transfected with Lipofectamine 3 000 using RFC2 small interfering RNA(siRNA) and control inhibitory sequence scaffold,respectively,and divided into RFC2 silenced expression group(si-RFC2) and inhibitory control group(si-NC).Transfect RFC2 overexpression plasmid(RFC2 plasmid) and blank control plasmid,and divide into RFC2 overexpression group(OE-RFC2) and overexpression control group(Vector).Cell proliferation ability was detected using Methylthiazolyldiphenyl-tetrazolium bromide(MTT) cell proliferation detection kit,cell migration ability was measured using cell scratch assay,and protein blotting assay was used to determine the expression levels of RFC2,p-PI3K,PI3K,p-Akt,and Akt proteins.Results Compared with the normal human renal tubular epithelial cell line HK-2,the RCC cell lines ACHN,786-O,Caki-1,KETR3,and OS-RC2 showed high expression of RFC2 protein(all P<0.001).MTT assay showed that the A490nm values of the si-RFC2 group were lower than those of the si-NC group at 0,24,48,and 72h(all P<0.05),while the A490nm values of the OE-RFC2 group were higher than those of the Vector group at 0,24,48,and 72h(all P<0.05).The scratch healing rate of the OE-RFC2 group was higher than that of the Vector group[(89.4±9.4)% vs(15.8±6.3)%,P<0.05].The cell scratch healing rate in the si-RFC2 group was lower than that in the si-NC group[(5.2±1.9)% vs(16.5±5.5)%,P<0.05].After upregulating RFC2 expression in KETR-3 cells,the relative expression level of RFC2 protein in the OE-RFC2 group was higher than that in the Vector group(1.04 ± 0.19 vs 0.25±0.03,P<0.05),the p-PI3K/PI3K ratio in the OE-RFC2 group was higher than that in the Vector group(1.15±0.23 vs 0.34±0.024,P<0.05),and the p-Akt/Akt ratio in the OE-RFC2 group was higher than that in the Vector group(1.26±0.25 vs 0.38± 0.022,P<0.05).After silencing the expression of RFC2,the relative expression level of RFC2 protein in the si-RFC2 group was lower than that in the si-NC group(0.16 ± 0.02 vs 1.08 ± 0.06,P<0.05),the p-PI3K/PI3K ratio in the si-RFC2 group was lower than that in the si-NC group(0.18 ± 0.04 vs 0.86±0.14,P<0.05),and the p-Akt/Akt ratio in the si-RFC2 group was lower than that in the si-NC group(0.10±0.01 vs 0.58±0.13,P<0.05).Conclusion RFC2 promotes the proliferation and migration of renal cell carcinoma cells,and the mechanism may be related to the activation of the PI3K/Akt signaling pathway.

Key words: replication activation factor C2, renal cell carcinoma, cell proliferation, cell migration, mechanism

[1] 肖梅仙 李洪波 匡黎. 肿瘤和肾周脂肪组织活化蛋白-α用于透明细胞肾细胞癌危险分层的研究[J]. 临床外科杂志, 2024, 32(7): 748-752.
[2] 李浩 于莹莹 宋祥伟 张鹤骞 滕立臣. 术前外周血炎症相关指标对肾透明细胞癌Fuhrman分级预测价值的研究[J]. 临床外科杂志, 2024, 32(5): 532-536.
[3] 董泓毅 刘殿刚. 胆汁反流发病机制与诊断及治疗研究进展[J]. 临床外科杂志, 2024, 32(5): 554-557.
[4] 王金霞 闵晓翠 王芙蓉 刘小央. 腹膜粘连的分子机制研究进展[J]. 临床外科杂志, 2024, 32(11): 1226-1229.
[5] 张舒婷 关海霞. 多发性内分泌腺瘤病1型的研究进展[J]. 临床外科杂志, 2023, 31(3): 201-204.
[6] 殷军锋 顾明. 沉默circ_0007385对结肠癌细胞增殖、迁移及凋亡的影响[J]. 临床外科杂志, 2022, 30(8): 762-766.
[7] 李锦楠 崔亮 肖旭仁 吴学杰 代晓飞 李景敏. 人源性肾癌异体移植模型的建立及分析[J]. 临床外科杂志, 2022, 30(8): 767-770.
[8] 梁鹏, 李万富. 先天性巨结肠相关性小肠结肠炎发病机制研究及治疗进展[J]. 临床外科杂志, 2021, 29(6): 587-589.
[9] 戴津东, 张兴明, 曾浩. 转移性肾癌减瘤性肾切除术的临床决策要点及挑战[J]. 临床外科杂志, 2021, 29(2): 112-116.
[10] 李干斌 韩加刚 王振军. 肥胖促进恶性肿瘤发生的机制探讨及研究进展[J]. 临床外科杂志, 2021, 29(10): 996-998.
[11] 王美才, 储传敏, 程文等. 老年前列腺增生症术后尿路感染以及细胞炎性机制分析[J]. 临床外科杂志, 2020, 28(11): 1066-1069.
[12] 黄柯, 刘王波, 刘涛. 钠氢交换体1调节肿瘤微环境对肿瘤细胞的影响[J]. 临床外科杂志, 2019, 27(9): 825-827.
[13] 于朋涛, 孙海军, 李之拓, 王鹏飞, 白晓东. Mirizzi综合征的诊治进展[J]. 临床外科杂志, 2019, 27(8): 721-723.
[14] 郭伍斌, 马新, 黎晖. Fbxw7过表达促进mTOR降解并抑制胃癌细胞迁移的研究[J]. 临床外科杂志, 2019, 27(5): 379-382.
[15] 钟春林 杨治力 樊友本. 散发性甲状旁腺瘤分子机制研究进展[J]. 临床外科杂志, 2012, 20(3): 213-213.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 胡善彪;余少杰;彭龙开. 婴幼儿供肾移植[J]. 临床外科杂志, 2016, 24(10): 741 .
[2] 石宇;刘学刚 . 冠状动脉旁路移植术后短期内应用强化他汀对患者出血风险的研究[J]. 临床外科杂志, 2016, 24(10): 750 .
[3] 齐卫鹏;王剑明;刘颜;等. 术前应用靛氰绿检测联合三维重建成像评估肝门部胆管癌肝脏储备功能[J]. 临床外科杂志, 2016, 24(10): 756 .
[4] 李义亮;张成;克力木;等. 完全腹腔镜下远端胃癌根治术的临床体会[J]. 临床外科杂志, 2016, 24(10): 769 .
[5] 张忠伟;刘扬;路明. 痔上黏膜环切术治疗直肠前突所致出口梗阻型便秘的疗效观察[J]. 临床外科杂志, 2016, 24(10): 774 .
[6] 周观金;彭昊;陈森. 全膝关节置换治疗膝关节炎术后早期镇痛的研究进展[J]. 临床外科杂志, 2016, 24(10): 804 .
[7] 万松林;刘韦成;吴云华;等. 胃间质瘤腹腔内破裂出血一例[J]. 临床外科杂志, 2016, 24(10): 807 .
[8] 陈凛;崔建新. 胃癌术后复发与再手术[J]. 临床外科杂志, 2016, 24(11): 813 .
[9] 杨钦;张再重;王烈. 空肠间置术在Siewert Ⅱ型食管胃结合部腺癌中的应用[J]. 临床外科杂志, 2016, 24(11): 816 .
[10] 应敏刚;杨春康. 腹腔镜胃癌根治术并发症的防治策略[J]. 临床外科杂志, 2016, 24(11): 819 .